Search Results - "LOEFFLER, D. A"

Refine Results
  1. 1

    Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions by Loeffler, D A, Connor, J R, Juneau, P L, Snyder, B S, Kanaley, L, DeMaggio, A J, Nguyen, H, Brickman, C M, LeWitt, P A

    Published in Journal of neurochemistry (01-08-1995)
    “…Oxidant-mediated damage is suspected to be involved in the pathogenesis of several neurodegenerative disorders. Iron promotes conversion of hydrogen peroxide…”
    Get more information
    Journal Article
  2. 2

    Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations by Patrias, L.M, Klaver, A.C, Coffey, M.P, Loeffler, D.A

    Published in Clinical and experimental immunology (01-09-2010)
    “…Alpha-synuclein is the major protein in Lewy bodies, the hallmark pathological finding in Parkinson's disease (PD) and dementia with Lewy bodies (DLB)…”
    Get full text
    Journal Article
  3. 3

    A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains by Connor, J R, Snyder, B S, Arosio, P, Loeffler, D A, LeWitt, P

    Published in Journal of neurochemistry (01-08-1995)
    “…The brain requires a ready supply of iron for normal neurological function, but free iron is toxic. Consequently, iron bioavailability must be stringently…”
    Get more information
    Journal Article
  4. 4

    Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders by Loeffler, D.A., LeWitt, P.A., Juneau, P.L., Sima, A.A.F., Nguyen, H.-U., DeMaggio, A.J., Brickman, C.M., Brewer, G.J., Dick, R.D., Troyer, M.D., Kanaley, L.

    Published in Brain research (04-11-1996)
    “…Ceruloplasmin (CP), the major plasma anti-oxidant and copper transport protein, is synthesized in several tissues, including the brain. We compared regional…”
    Get full text
    Journal Article
  5. 5

    L‐DOPA Does Not Enhance Hydroxyl Radical Formation in the Nigrostriatal Dopamine System of Rats with a Unilateral 6‐Hydroxydopamine Lesion by Camp, Dianne M., Loeffler, David A., LeWitt, Pater A.

    Published in Journal of neurochemistry (01-03-2000)
    “…The debate about the toxicity of L‐DOPA to dopaminergic neurons has not been resolved. Even though enzymatic and nonenzymatic metabolism of L‐DOPA can produce…”
    Get full text
    Journal Article
  6. 6

    Influence of tumour physico-chemical conditions on interleukin-2-stimulated lymphocyte proliferation by LOEFFLER, D. A, JUNEAU, P. L, MASSERANT, S

    Published in British journal of cancer (01-10-1992)
    “…The proliferative response of murine lymphocytes to interleukin-2 (IL-2) was examined under physico-chemical conditions present in solid tumours, namely low…”
    Get full text
    Journal Article
  7. 7

    Ceruloplasmin immunoreactivity in neurodegenerative disorders by Loeffler, D A, Sima, A A, LeWitt, P A

    Published in Free radical research (01-01-2001)
    “…Ceruloplasmin (CP) is a 132 kd cuproprotein which, together with transferrin, provides the majority of anti-oxidant capacity in serum. Increased iron…”
    Get more information
    Journal Article
  8. 8

    Purine-induced alterations of dopamine metabolism in rat pheochromocytoma PC12 cells by Loeffler, D.A, Camp, D.M, Juneau, P.L, Harel, E, LeWitt, P.A

    Published in Brain research bulletin (01-08-2000)
    “…Studies with cerebrospinal fluid from subjects with Parkinson’s disease suggest that purine abnormalities may be present in this disorder. The effects of…”
    Get full text
    Journal Article
  9. 9

    Cerebrospinal Fluid C3a Increases with Age, But Does Not Increase Further in Alzheimer’s Disease by Loeffler, D.A, Brickman, C.M, Juneau, P.L, Perry, M.F, Pomara, N, LeWitt, P.A

    Published in Neurobiology of aging (01-09-1997)
    “…Complement activation is present in the brain in Alzheimer’s disease (AD), and C1q concentrations are decreased in AD cerebrospinal fluid (CSF). To determine…”
    Get full text
    Journal Article
  10. 10

    Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease by Loeffler, D A, DeMaggio, A J, Juneau, P L, Brickman, C M, Mashour, G A, Finkelman, J H, Pomara, N, LeWitt, P A

    “…Although the pathophysiology of Alzheimer's disease (AD) and Parkinson's disease (PD) is unknown, altered brain antioxidative mechanisms have been found in…”
    Get more information
    Journal Article
  11. 11

    Effects of enhanced striatal dopamine turnover in vivo on glutathione oxidation by Loeffler, D A, DeMaggio, A J, Juneau, P L, Havaich, M K, LeWitt, P A

    Published in Clinical neuropharmacology (01-08-1994)
    “…In Parkinson's disease (PD), a compensatory increase in dopamine (DA) turnover occurs in the remaining nigrostriatal dopaminergic neurons, resulting in greater…”
    Get more information
    Journal Article
  12. 12

    Altered Guanosine and Guanine Concentrations in Rabbit Striatum Following Increased Dopamine Turnover by Loeffler, D.A, LeWitt, P.A, Juneau, P.L, Camp, D.M, DeMaggio, A.J, Milbury, P, Matson, W.R, Rathbone, M.P

    Published in Brain research bulletin (01-02-1998)
    “…The significance of guanine nucleotides and nucleosides in neurodegenerative disorders is suggested by recent reports that these molecules enhance neurite…”
    Get full text
    Journal Article
  13. 13

    Influence of repeated levodopa administration on rabbit striatal serotonin metabolism, and comparison between striatal and CSF alterations by LOEFFLER, D. A, LEWITT, P. A, JUNEAU, P. L, CAMP, D. M, DEMAGGIO, A. J, HAVAICH, M. K, MILBURY, P. E, MATSON, W. R

    Published in Neurochemical research (01-12-1998)
    “…Parkinson's disease (PD) is characterized by decreased striatal dopamine, but serotonin (5-HT) is also reduced. Because 5-HT decreases following a single…”
    Get full text
    Journal Article
  14. 14

    Time-dependent effects of levodopa on regional brain dopamine metabolism and lipid peroxidation by Loeffler, D.A, LeWitt, P.A, Juneau, P.L, Camp, D.M, Arnold, L.A, Hyland, K

    Published in Brain research bulletin (01-12-1998)
    “…Levodopa treatment in Parkinson’s disease has been suggested to contribute to disease progression through free radical generation. We compared the time course…”
    Get full text
    Journal Article
  15. 15

    Measurement of acute phase proteins in the rat brain : Contribution of vascular contents by LOEFFLER, D. A, LINDER, M. C, ZAMANY, M, HAREL, E, PAUL, M. A, BAUMANN, H, LEWITT, P. A

    Published in Neurochemical research (01-10-1999)
    “…A localized acute phase response occurs in the brain in Alzheimer's disease. Acute phase proteins have previously been measured in brain homogenates to…”
    Get full text
    Journal Article
  16. 16

    Immunocytochemical detection of anti-hippocampal antibodies in Alzheimer's disease and normal cerebrospinal fluid by LOEFFLER, D. A, JUNEAU, P. L, NGUYEN, H.-U, NAJMAN, D, POMARA, N, LEWITT, P. A

    Published in Neurochemical research (01-02-1997)
    “…Immunocytochemical staining was performed to investigate the presence of anti-hippocampal antibodies in cerebrospinal fluid (CSF) from patients with probable…”
    Get full text
    Journal Article
  17. 17

    Enzyme-linked immunosorbent assay for detection of leukocidin toxin from Staphylococcus aureus in bovine milk samples by Loeffler, D.A, Creasy, M.T, Norcross, N.L, Paape, M.J

    Published in Journal of Clinical Microbiology (01-07-1988)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  18. 18

    Lymphocytic infiltration and cytotoxicity under hypoxic conditions in the EMT6 mouse mammary tumor by Loeffler, D A, Keng, P C, Baggs, R B, Lord, E M

    Published in International journal of cancer (15-03-1990)
    “…Infiltration of lymphocytes, neutrophils and macrophages was evaluated in hypoxic and well-oxygenated areas of the EMT6 mouse mammary adenocarcinoma, by in…”
    Get more information
    Journal Article
  19. 19

    Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid by LOEFFLER, D. A, LEWITT, P. A, DEMAGGIO, A. J, JUNEAU, P. L, MILBURY, P. E, MATSON, W. R

    “…Though depletion of CSF homovanillic acid (HVA) concentration has often been regarded as a direct indicator of dopamine (DA) deficiency in Parkinson's Disease…”
    Get full text
    Journal Article
  20. 20